Newer Studies in Combination Therapy
Which patients are appropriate for dual upfront versus sequential PAH therapy? This expert roundtable looks at newer studies of combination therapy in the treatment of pulmonary arterial hypertension, including AMBITION and GRIPHON. The panel discusses the clinical implications to patients in targeting multiple pathways. Moderated by Sean Studer, MD, MSc. Discussants: Richard Channick, MD, Vallerie McLaughlin, MD, Martha Kingman Liberty, FNP-C, DNP.